BioPharm America 2014: Interview with Ankit Mahadevia, Spero Therapeutics

July 7, 2015
John Carroll, Editor-in-Chief of FierceBiotech, interviews Ankit Mahadevia, CEO of Spero Therapeutics and a 2014 Fierce 15 winner. Mahadevia discusses the value and potential of Spero’s lead technologies and the challenges involved in the development of novel therapies to treat highly resistant bacterial infections. Find more videos and articles at http://www.partnering360.com/insight For more information on BioPharm America, visit our webpage: http://www.ebdgroup.com/bpa/index.php
Previous Video
BIO-Europe 2014: Interview with Marietta Wu, Zai Lab
BIO-Europe 2014: Interview with Marietta Wu, Zai Lab

Over the past decade China has been a market access story—offering the allure of a high-growth and massive ...

Next Video
BioPharm America 2014: Interview with Jeffrey Stein, Cidara Therapeutics
BioPharm America 2014: Interview with Jeffrey Stein, Cidara Therapeutics

John Carroll, Editor-in-Chief of FierceBiotech, interviews Jeffrey Stein, CEO of Cidara Therapeutics, a 201...